Natalizumab therapy is associated with greater variability in JC Virus Antibody levels

被引：0
|
作者：
Peters, John [1 ]
Williamson, Eric [1 ]
机构：
[1] Univ Penn, Dept Neurol, Perelman Sch Med, Philadelphia, PA 19104 USA
来源：
NEUROLOGY | 2017年 / 88卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P5.370
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Asymptomatic Reactivation of JC Virus in Patients Treated with Natalizumab
    Chen, Yiping
    Bord, Evelyn
    Tompkins, Troy
    Miller, Janice
    Tan, Chen S.
    Kinkel, R. Philip
    Stein, Marion C.
    Viscidi, Raphael P.
    Ngo, Long H.
    Koralnik, Igor J.
    NEW ENGLAND JOURNAL OF MEDICINE, 2009, 361 (11): : 1067 - 1074
  • [22] Seeking insight into natalizumab, JC virus reactivation and PML
    Reactions Weekly, 2009, 1270 (1) : 3 - 3
  • [23] JC and BK virus in natalizumab-treated patients
    Barrett, Kathleen V.
    Puccio, Lauren M.
    Brydon, Edward W.
    Sadiq, Saud A.
    MULTIPLE SCLEROSIS, 2008, 14 : S176 - S177
  • [24] Anti-JC Virus Antibody Titer Changes during Natalizumab Treatment in a Swedish MS Cohort
    Warnke, Clemens
    Subramanyam, Meena
    Bergstrom, Tomas
    Goelz, Susan
    Plavina, Tatiana
    Kockum, Ingrid
    Rahbar, Afsar
    Olsson, Tomas
    Hillert, Jan
    Fogdell-Hahn, Anna
    NEUROLOGY, 2012, 78
  • [25] JC virus in multiple sclerosis patients treated with natalizumab
    Dominguez-Mozo, M. I.
    Alvarez-Lafuente, R.
    Garcia-Montojo, M.
    De Las Heras, V.
    Bartolome, M.
    Garcia-Martinez, A.
    Arroyo, R.
    MULTIPLE SCLEROSIS, 2009, 15 (09): : S86 - S86
  • [26] Increase in JC virus antibody levels during pregnancy in MS patients
    Atula, S.
    Hedman, K.
    Jouhi, L.
    Jalkanen, A.
    Airas, L.
    MULTIPLE SCLEROSIS JOURNAL, 2015, 21 : 449 - 450
  • [27] Detection of polyomavirus JC DNA and anti-JCV antibody in MS patients under natalizumab therapy
    Clausi, V.
    Martelli, F.
    Repice, A. M.
    Mechi, C.
    Magnani, E.
    Massacesi, L.
    Azzi, A.
    Giannecchini, S.
    MULTIPLE SCLEROSIS JOURNAL, 2012, 18 : 467 - 467
  • [28] Impact of JC virus seroconversion and viral antibody titre on patients' decision making on receiving natalizumab for multiple sclerosis
    Lusher, W.
    Rog, D.
    Talbot, P.
    Mihalova, T.
    Sharaf, N.
    Pace, A.
    MULTIPLE SCLEROSIS JOURNAL, 2016, 22 : 794 - 795
  • [29] Changes in JC Virus-Specific T Cell Responses during Natalizumab Treatment and in Natalizumab-Associated Progressive Multifocal Leukoencephalopathy
    Perkins, Molly R.
    Ryschkewitsch, Caroline
    Liebner, Julia C.
    Monaco, Maria Chiara G.
    Himelfarb, Danielle
    Ireland, Sara
    Roque, Annelys
    Edward, Heather L.
    Jensen, Peter N.
    Remington, Gina
    Abraham, Thomas
    Abraham, Jaspreet
    Greenberg, Benjamin
    Kaufman, Charles
    LaGanke, Chris
    Monson, Nancy L.
    Xu, Xiaoning
    Frohman, Elliot
    Major, Eugene O.
    Douek, Daniel C.
    PLOS PATHOGENS, 2012, 8 (11):
  • [30] Asymptomatic Reactivation of JC Virus in Patients Treated with Natalizumab.
    Gorelik, Leonid
    Goelz, Susan
    Sandrock, Alfred W.
    NEW ENGLAND JOURNAL OF MEDICINE, 2009, 361 (25): : 2487 - 2488
12345